H. Yoshiji et al., ENHANCED RNA EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) IN HUMAN BREAST-CANCER, International journal of cancer, 69(2), 1996, pp. 131-134
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is known to have at
least 2 distinct types of activity, i.e., as a regulator of collagenol
ytic activity, and erythroid potentiating activity (ERA). In this stud
y, we examined the expression of TIMP-1 in human mammary carcinomas, n
on-malignant breast tissues and benign breast tumors. A total of 53 sa
mples were subjected to Northern-blot analysis, including 23 of primar
y breast cancer, 26 of non-malignant breast tissues, and 4 of benign t
umors. Of the 53 samples, 10 were paired malignant and non-malignant b
reast-tissue samples from the same patient. TIMP-1 RNA expression was
significantly higher in the malignant tumor tissues than in the non-ma
lignant counterpart. Similar differences were observed in the level of
TIMP-1 protein expression in the paired breast samples examined. More
over, breast-cancer cell lines secreted larger amounts of TIMP-1 in vi
tro than non-neoplastic breast epithelial lines. The up-regulation of
TIMP-1 expression in breast cancer may suggest that TIMP-1 has an addi
tional role to that of metalloproteinase inhibitor. (C) 1996 Wiley-Lis
s, Inc.